IKCS 2022

Conference Coverage

Scoring System Differentiates Malignant and Benign Renal Masses

By

John Schieszer, MA

A validated algorithm for assessing solid renal masses could be useful in clinical practice.

How Patients Choose Small Renal Mass Treatment Characterized

By

John Schieszer, MA

Patients choosing active surveillance perceived cancer and metastasis risks to be lower compared with those opting for surgery and ablation, a study showed.

Progression Criteria Could Improve Active Surveillance for Renal Masses

By

John Schieszer, MA

Recent findings may be useful for patient counseling and in designing active surveillance research studies.

Biomarker Could Improve Management of Renal Medullary Carcinoma

By

John Schieszer, MA

Study showed that 82% of patients had elevated CA-125 levels at any point during their disease course.

Post-RCC Treatment ESKD Risk Factors Identified

By

Jody A. Charnow

A study of patients treated for RCC found that radical nephrectomy, male sex, diabetes, hypertension, and chronic kidney disease are risk factors for end-stage kidney disease, according to investigators.

Exercise, Physical Activity Beneficial in Kidney Cancer Cases

By

John Schieszer, MA

In a study of patients who had ever been diagnosed with kidney cancer, those who reported exercise or physical activity in the past 30 days had reduced likelihood of reporting worse physical and mental health.

DNA Assay May Distinguish Responses to mRCC Immunotherapy

By

Jody A. Charnow

The TARDIS assay could be used in studies to identify appropriate candidates for discontinuation of immune checkpoint inhibitors.

Treatment Advances Have Upped Survival in Metastatic Kidney Cancer

By

Jody A. Charnow

Investigators in Austria studied overall survival in 914 patients diagnosed with mRCC from July 1985 to September 2020.

Efficacy, Safety of Triple Combo for Advanced Kidney Cancer Probed

By

Natasha Persaud

Study provides preliminary data on triple therapy for advanced RCC while clinicians await definitive answers from the ongoing phase 3 COSMIC-313 trial.

Kidney Cancer Metastases Effectively Treated With Robotic Radiosurgery

By

Jody A. Charnow

Investigators examined outcomes of robotic radiosurgery in patients with lung, visceral, and lymph node metastases from renal cell carcinoma.

COVID-19 mRNA Vaccine Efficacy Wanes Over Time in RCC Cases

By

Natasha Persaud

Strategies, such as booster doses, appear warranted in this population.

Immune Checkpoint Inhibitors Prolong Survival in mRCC, Real-World Data Show

By

Natasha Persaud

Use of immune checkpoint inhibitors for any line of treatment was beneficial, investigators reported.

Frontline Immunotherapy Appears Effective in mRCC With Poor Performance Status

By

Natasha Persaud

Patients with poor performance status have been excluded from pivotal trials on metastatic renal cell carcinoma.

Lenvatinib+Pembrolizumab Adverse Reactions in Advanced RCC Characterized

By

Jody A. Charnow

Investigators describe the type and frequency of adverse reactions and how clinicians managed them.